Abstract:We investigated the impact of time, storage temperature, and dimethyl sulfoxide (DMSO) on the viability of HSCs, as well as on apoptotic changes in thawed CB. Materials & Methods: Thirteen units of cryopreserved CB were thawed and half of each sample was stored at room temperature (RT) and the other half at 4℃, without removing or diluting DMSO. Flow cytometry was employed to enumerate total nucleated cells (TNCs), total/viable CD34+ cells, and early/late apoptotic cells using anti-CD45, anti-CD34, and annexin… Show more
“…The results of stability studies of thawed UCB samples were conflicting. Lee et al 54 in their study showed that thawed UCB samples were stable up to 6 h after thawing, regardless of whether samples were stored at room temperature or at 4°C. On the other hand, Huang and colleagues reported that CD34+ cell viability decreased significantly after only 20 min when thawed UCB samples were stored at RT 55 .…”
Section: Quality Control and Validation Of Flow Cytometry Methodsmentioning
confidence: 99%
“…Sample stability study is an important part of validation of the protocol used for quality assessment, especially when implementing a new type of cell therapy product. Several studies have examined the stability of fresh leukapheresis samples and thawed cryopreserved UCB samples 37,39,54,55 . The results showed that fresh leukapheresis samples were stable up to 24 h stored at 4°C 37,39 .…”
Section: Quality Control and Validation Of Flow Cytometry Methodsmentioning
“…Several studies have examined the stability of fresh leukapheresis samples and thawed cryopreserved UCB samples. 37,39,54,55 The results showed that fresh leukapheresis samples were stable up to 24 h stored at 4 C. 37,39 The results of stability studies of thawed UCB samples were conflicting. Lee et al 54 in their study showed that thawed UCB samples were stable up to 6 h after thawing, regardless of whether samples were stored at room temperature or at 4 C. On the other hand, Huang and colleagues reported that CD34+ cell viability decreased significantly after only 20 min when thawed UCB samples were stored at RT.…”
Section: Stability Of the Cellular Therapy Product Samplesmentioning
confidence: 99%
“…37,39,54,55 The results showed that fresh leukapheresis samples were stable up to 24 h stored at 4 C. 37,39 The results of stability studies of thawed UCB samples were conflicting. Lee et al 54 in their study showed that thawed UCB samples were stable up to 6 h after thawing, regardless of whether samples were stored at room temperature or at 4 C. On the other hand, Huang and colleagues reported that CD34+ cell viability decreased significantly after only 20 min when thawed UCB samples were stored at RT. 55 Krasna et al 56 evaluated the stability of the HSC products after immunoselection and reported that CD34+ cells after selection were less stable than CD34+ cells in leukapheresis product during refrigerated storage up to 6 days.…”
Section: Stability Of the Cellular Therapy Product Samplesmentioning
Cellular therapy nowadays includes various products from haematopoietic stem cells (HSC) collected from bone marrow, peripheral blood, and umbilical cord blood to more complex adoptive immune therapy for the treatment of malignant diseases, and gene therapy for inherited immune deficiencies. Broader utilization of cellular therapy
“…The results of stability studies of thawed UCB samples were conflicting. Lee et al 54 in their study showed that thawed UCB samples were stable up to 6 h after thawing, regardless of whether samples were stored at room temperature or at 4°C. On the other hand, Huang and colleagues reported that CD34+ cell viability decreased significantly after only 20 min when thawed UCB samples were stored at RT 55 .…”
Section: Quality Control and Validation Of Flow Cytometry Methodsmentioning
confidence: 99%
“…Sample stability study is an important part of validation of the protocol used for quality assessment, especially when implementing a new type of cell therapy product. Several studies have examined the stability of fresh leukapheresis samples and thawed cryopreserved UCB samples 37,39,54,55 . The results showed that fresh leukapheresis samples were stable up to 24 h stored at 4°C 37,39 .…”
Section: Quality Control and Validation Of Flow Cytometry Methodsmentioning
“…Several studies have examined the stability of fresh leukapheresis samples and thawed cryopreserved UCB samples. 37,39,54,55 The results showed that fresh leukapheresis samples were stable up to 24 h stored at 4 C. 37,39 The results of stability studies of thawed UCB samples were conflicting. Lee et al 54 in their study showed that thawed UCB samples were stable up to 6 h after thawing, regardless of whether samples were stored at room temperature or at 4 C. On the other hand, Huang and colleagues reported that CD34+ cell viability decreased significantly after only 20 min when thawed UCB samples were stored at RT.…”
Section: Stability Of the Cellular Therapy Product Samplesmentioning
confidence: 99%
“…37,39,54,55 The results showed that fresh leukapheresis samples were stable up to 24 h stored at 4 C. 37,39 The results of stability studies of thawed UCB samples were conflicting. Lee et al 54 in their study showed that thawed UCB samples were stable up to 6 h after thawing, regardless of whether samples were stored at room temperature or at 4 C. On the other hand, Huang and colleagues reported that CD34+ cell viability decreased significantly after only 20 min when thawed UCB samples were stored at RT. 55 Krasna et al 56 evaluated the stability of the HSC products after immunoselection and reported that CD34+ cells after selection were less stable than CD34+ cells in leukapheresis product during refrigerated storage up to 6 days.…”
Section: Stability Of the Cellular Therapy Product Samplesmentioning
Cellular therapy nowadays includes various products from haematopoietic stem cells (HSC) collected from bone marrow, peripheral blood, and umbilical cord blood to more complex adoptive immune therapy for the treatment of malignant diseases, and gene therapy for inherited immune deficiencies. Broader utilization of cellular therapy
Although the use of cryoprotectant dimethyl sulfoxide (DMSO) is the gold standard in cryopreservation of hematopoietic stem cells, it is well known that it has a negative effect on cell viability. The aim of this prospective study was to examine how the length of post-thaw exposure to DMSO affects the cell viability and stability of peripheral blood stem cell (PBSC) samples. Additionally, the effects of donor type and pre-cryopreservation storage time on post-thaw viability during the stability study were evaluated. In 30 autologous and 30 allogeneic PBSC samples viable CD34+, CD14+, CD19+, CD16+/56+, and CD3+ cells were determined immediately after thawing, and one-and three-hours post-thaw.
Analysis of the absolute count of viable cells in thawed samples showed a significant difference between all measurement points for CD34+ (p < 0.001), CD14+ (p < 0.001), and CD19+ cells (p < 0.001). No significant differences were observed for post-thaw stability of allogeneic samples analysed between products stored before cryopreservation ≥ 24 hours (N = 20), and those stored < 24 hours (N = 10), except for viable CD3+/CD4+ cells after three hours post-thaw (p = 0.028). In conclusion, DMSO had different effects on leukocyte subpopulations in cryopre-served PBSC samples. The type of donors and the length of storage before cryopreservation did not affect the post-thaw stability of cryopreserved PBSC samples.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.